Efficacy of Whole Brain Radiotherapy Combined with Fractionated Stereotactic Radiotherapy in Metastatic Brain Tumors, and Prognostic Factors.
Trichostatin A, a histone deacetylase Inhibitor, potentiated cytotoxic effect of ionizing radiation in human head and neck cancer cell lines.
Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor
Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma
A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2/M arrest in human carcinoma cells.
Leptomycin B increases radiosensitization by trichostain A in HeLa cells.
Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed.
The Role of Radiotherapy in the Treatment of Newly Diagnosed Supratentorial Low-grade Oligodendrogliomas: Comparative Analysis with Immediate Radiotherapy versus Surgery Alone.
Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer
PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations.
Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin. Exp. Metastasis
Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma
Image-guided stereotactic body radiation therapy for localized prostate cancer
Absorbed Dose Determination for a Biological Sample Irradiated by Gamma Rays from a Cs-137 Source
Study on the Evaluation of TRS-398 Quality Factors with Central Electrode Corrections for Small Cylindrical Chambers
Bilateral orbital metastases from breast cancer: a case report of successful palliation using stereotactic radiotherapy
DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity
Changes in biologic markers of oxidative stress and plasma endotoxin levels in gynecologic cancer patients treated with pelvic radiotherapy: a pilot study